Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cerilliant
Moodys
Covington
Teva
Cantor Fitzgerald
Farmers Insurance
Accenture
Chinese Patent Office
Federal Trade Commission
Mallinckrodt

Generated: October 22, 2017

DrugPatentWatch Database Preview

Mylan Institutional Company Profile

« Back to Dashboard

What is the competitive landscape for MYLAN INSTITUTIONAL, and when can generic versions of MYLAN INSTITUTIONAL drugs launch?

MYLAN INSTITUTIONAL has fifty-six approved drugs.

There is one US patent protecting MYLAN INSTITUTIONAL drugs.

Summary for Applicant: Mylan Institutional

US Patents:1
Tradenames:49
Ingredients:47
NDAs:56
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Institutional
PENTOSTATIN
pentostatin
INJECTABLE;INJECTION203554-001Sep 19, 2014APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
DEXRAZOXANE HYDROCHLORIDE
dexrazoxane hydrochloride
INJECTABLE;INJECTION200752-001Oct 19, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
METHADONE HYDROCHLORIDE
methadone hydrochloride
INJECTABLE;INJECTION021624-001Approved Prior to Jan 1, 1982RXYesYes► Subscribe► Subscribe► Subscribe
Mylan Institutional
PYRIDOXINE HYDROCHLORIDE
pyridoxine hydrochloride
INJECTABLE;INJECTION204879-001Jul 14, 2016APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
MELPHALAN HYDROCHLORIDE
melphalan hydrochloride
INJECTABLE;INJECTION090299-001Oct 27, 2009DISCNNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
OCTREOTIDE ACETATE (PRESERVATIVE FREE)
octreotide acetate
INJECTABLE;INJECTION079198-002Feb 10, 2011APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
NICARDIPINE HYDROCHLORIDE
nicardipine hydrochloride
INJECTABLE;INJECTION090664-001Nov 17, 2009APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
COSYNTROPIN
cosyntropin
INJECTABLE;INJECTION090574-001Dec 17, 2009APRXNoNo► Subscribe► Subscribe► Subscribe
Mylan Institutional
AMIODARONE HYDROCHLORIDE
amiodarone hydrochloride
INJECTABLE;INJECTION076217-001Oct 15, 2002APRXNoYes► Subscribe► Subscribe► Subscribe
Mylan Institutional
ENLON-PLUS
atropine sulfate; edrophonium chloride
INJECTABLE;INJECTION019678-001Nov 6, 1991RXYesYes► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Mylan Institutional

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-003Jul 12, 1996► Subscribe► Subscribe
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-001Jul 12, 1996► Subscribe► Subscribe
Mylan Institutional
ENLON-PLUS
atropine sulfate; edrophonium chloride
INJECTABLE;INJECTION019677-001Nov 6, 1991► Subscribe► Subscribe
Mylan Institutional
ENLON-PLUS
atropine sulfate; edrophonium chloride
INJECTABLE;INJECTION019678-001Nov 6, 1991► Subscribe► Subscribe
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-002Jul 12, 1996► Subscribe► Subscribe
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-002Jul 12, 1996► Subscribe► Subscribe
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-003Jul 12, 1996► Subscribe► Subscribe
Mylan Institutional
ULTIVA
remifentanil hydrochloride
INJECTABLE;INJECTION020630-001Jul 12, 1996► Subscribe► Subscribe
Mylan Institutional
SULFAMYLON
mafenide acetate
CREAM;TOPICAL016763-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Mylan Institutional
RIMSO-50
dimethyl sulfoxide
SOLUTION;INTRAVESICAL017788-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for MYLAN INSTITUTIONAL drugs

Drugname Dosage Strength Tradename Submissiondate
remifentanil hydrochloride
for Injection1 mg/vial, 2 mg/vial and 5 mg/vial
ULTIVA
12/27/2013
argatroban in sodium chloride
Injection1 mg/mL, 50 mL vials
ARGATROBAN
12/16/2011
argatroban
Injection100 mg/mL, 2.5 mL vials
ARGATROBAN
9/24/2007

Similar Applicant Names

Individual applicants are sometimes listed under multiple names.
Here is a list of applicants with similar names.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Accenture
Federal Trade Commission
Moodys
Farmers Insurance
Julphar
Queensland Health
Chubb
Cerilliant
Healthtrust

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot